valdecoxib has been researched along with deracoxib in 1 studies
Studies (valdecoxib) | Trials (valdecoxib) | Recent Studies (post-2010) (valdecoxib) | Studies (deracoxib) | Trials (deracoxib) | Recent Studies (post-2010) (deracoxib) |
---|---|---|---|---|---|
375 | 71 | 86 | 54 | 12 | 26 |
Protein | Taxonomy | valdecoxib (IC50) | deracoxib (IC50) |
---|---|---|---|
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.0501 | |
Cyclooxygenase-2 | Canis lupus familiaris (dog) | 0.63 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baurin, N; Chavatte, P; Lesieur, D; Marot, C; Yous, S | 1 |
1 other study(ies) available for valdecoxib and deracoxib
Article | Year |
---|---|
Three-dimensional quantitative structure-activity relationships of cyclo-oxygenase-2 (COX-2) inhibitors: a comparative molecular field analysis.
Topics: Benzene Derivatives; Binding Sites; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cyclopentanes; Imidazoles; Isoenzymes; Isoxazoles; Models, Molecular; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Pyrroles; Quantitative Structure-Activity Relationship; Spiro Compounds; Thiophenes | 2001 |